ATE130047T1 - Charakterisierung von human-leukocyt-antigen. - Google Patents
Charakterisierung von human-leukocyt-antigen.Info
- Publication number
- ATE130047T1 ATE130047T1 AT91300965T AT91300965T ATE130047T1 AT E130047 T1 ATE130047 T1 AT E130047T1 AT 91300965 T AT91300965 T AT 91300965T AT 91300965 T AT91300965 T AT 91300965T AT E130047 T1 ATE130047 T1 AT E130047T1
- Authority
- AT
- Austria
- Prior art keywords
- amplification
- hla
- length polymorphism
- dna
- characterization
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 238000012512 characterization method Methods 0.000 title 1
- 210000000265 leukocyte Anatomy 0.000 title 1
- 239000012634 fragment Substances 0.000 abstract 3
- 230000003321 amplification Effects 0.000 abstract 2
- 238000003199 nucleic acid amplification method Methods 0.000 abstract 2
- 239000002773 nucleotide Substances 0.000 abstract 2
- 125000003729 nucleotide group Chemical group 0.000 abstract 2
- 238000003752 polymerase chain reaction Methods 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 102000006354 HLA-DR Antigens Human genes 0.000 abstract 1
- 108010058597 HLA-DR Antigens Proteins 0.000 abstract 1
- 238000012408 PCR amplification Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6858—Allele-specific amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB909002625A GB9002625D0 (en) | 1990-02-06 | 1990-02-06 | Human leukocyte antigen typing |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE130047T1 true ATE130047T1 (de) | 1995-11-15 |
Family
ID=10670500
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT91300965T ATE130047T1 (de) | 1990-02-06 | 1991-02-06 | Charakterisierung von human-leukocyt-antigen. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US5552275A (de) |
| EP (1) | EP0443748B1 (de) |
| AT (1) | ATE130047T1 (de) |
| AU (1) | AU646655B2 (de) |
| CA (1) | CA2035813A1 (de) |
| DE (1) | DE69114323T2 (de) |
| GB (1) | GB9002625D0 (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE164630T1 (de) * | 1990-12-06 | 1998-04-15 | Hoffmann La Roche | Verfahren und reagenzien für die karakterisierung von hla-drbeta-dns |
| JPH06505391A (ja) * | 1991-03-06 | 1994-06-23 | リージェント オブ ザ ユニバーシティー オブ ミネソタ | Ｄｎａ配列化に基づくｈｌａタイピング |
| US5976789A (en) * | 1991-07-17 | 1999-11-02 | Bio Merieux | System of probes enabling HLA-DR typing to be performed, and typing method using said probes |
| FR2679252B1 (fr) * | 1991-07-17 | 1993-12-10 | Bio Merieux | Systeme de sondes permettant d'effectuer le typage hla dr, et procede de typage utilisant lesdites sondes. |
| GB9206567D0 (en) * | 1992-03-25 | 1992-05-06 | Univ Bristol | Dna analysis |
| WO1994021818A1 (en) * | 1993-03-18 | 1994-09-29 | N.V. Innogenetics S.A. | Process for typing hla-b using specific primers and probes sets |
| WO1995001453A1 (en) * | 1993-07-01 | 1995-01-12 | The Board Of Trustees Of The Leland Stanford Junior University | A heteroduplex mobility assay for the analysis of nucleic acid sequence diversity |
| AU6223098A (en) * | 1997-02-14 | 1998-09-08 | Medical Research Council | Method of determining susceptibility to late-onset alzheimer's disease and dementia with lewy bodies |
| EP0887423A1 (de) * | 1997-06-26 | 1998-12-30 | Biotest Ag | Verfahren zur Erkennung von Histokompatibilitätsantigenlocus der Klasse II |
| EP2186911B1 (de) * | 1997-06-26 | 2015-01-21 | BIO-Rad Medical Diagnostics GmbH | Verfahren zur Bestimmung des Histocompatibilitätsantigenlokus Klasse II |
| WO1999007885A2 (de) * | 1997-08-06 | 1999-02-18 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Verwendung von primern für universelle fingerprint-analysen |
| EP0953650A1 (de) | 1998-04-20 | 1999-11-03 | Innogenetics N.V. | Verfahren für die HLA Typisierung |
| EP1536021A1 (de) * | 2003-11-27 | 2005-06-01 | Consortium National de Recherche en Genomique (CNRG) | Methode zur Typisierung von HLA |
| US20090069190A1 (en) * | 2006-10-17 | 2009-03-12 | Invitrogen Corporation | Methods for hla typing |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4582788A (en) * | 1982-01-22 | 1986-04-15 | Cetus Corporation | HLA typing method and cDNA probes used therein |
| DK105582A (da) * | 1982-03-11 | 1983-09-12 | Nordisk Insulinlab | Fremgangsmaade til bestemmelse af humane hla-d(r) vaevstyper og gensonde til brug ved fremgangsmaaden |
| CA1254114A (en) * | 1984-05-07 | 1989-05-16 | Allied Corporation | Displacement polynucleotide assay employing recombination protein and diagnostic kit |
| DK171161B1 (da) * | 1985-03-28 | 1996-07-08 | Hoffmann La Roche | Fremgangsmåde til påvisning af forekomst eller fravær af mindst én specifik nukleinsyresekvens i en prøve eller til skelnen mellem to forskellige nukleinsyresekvenser i denne prøve |
| US5310893A (en) * | 1986-03-31 | 1994-05-10 | Hoffmann-La Roche Inc. | Method for HLA DP typing |
| US6194561B1 (en) * | 1986-03-13 | 2001-02-27 | Roche Molecular Systems, Inc. | Characterization and detection of sequences associated with autoimmune diseases |
| CA1284931C (en) * | 1986-03-13 | 1991-06-18 | Henry A. Erlich | Process for detecting specific nucleotide variations and genetic polymorphisms present in nucleic acids |
| WO1989001050A1 (en) * | 1987-07-31 | 1989-02-09 | The Board Of Trustees Of The Leland Stanford Junior University | Selective amplification of target polynucleotide sequences |
| JP2634208B2 (ja) * | 1987-11-13 | 1997-07-23 | パイオニア・ハイ―ブレツド・インターナシヨナル・インコーポレイテツド | 制限断片長多型性分析方法及びその装置 |
| WO1989007149A1 (en) * | 1988-01-28 | 1989-08-10 | Mayo Foundation For Medical Education And Research | Genomic amplification with direct sequencing |
| DE68928853T2 (de) * | 1988-05-20 | 1999-08-05 | Cetus Corp., Emeryville, Calif. | Befestigung von sequenzspezifischen proben |
| JP2781438B2 (ja) * | 1988-10-20 | 1998-07-30 | モーリィ，アリグザンダー，アラン | 白血病及びリンパ腫におけるモノクローナリテイーの診断法 |
| DE3909354A1 (de) * | 1989-03-22 | 1990-09-27 | Hoechst Ag | Ferroelektrische fluessigkristallsysteme mit hoher spontaner polarisation und guten orientierungseigenschaften |
| AU5645690A (en) * | 1989-05-05 | 1990-11-29 | Lifecodes Corporation | Method for genetic analysis of a nucleic acid sample |
-
1990
- 1990-02-06 GB GB909002625A patent/GB9002625D0/en active Pending
-
1991
- 1991-02-06 AT AT91300965T patent/ATE130047T1/de not_active IP Right Cessation
- 1991-02-06 DE DE69114323T patent/DE69114323T2/de not_active Expired - Fee Related
- 1991-02-06 EP EP91300965A patent/EP0443748B1/de not_active Expired - Lifetime
- 1991-02-06 AU AU70276/91A patent/AU646655B2/en not_active Ceased
- 1991-02-06 CA CA002035813A patent/CA2035813A1/en not_active Abandoned
-
1994
- 1994-02-23 US US08/200,949 patent/US5552275A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU7027691A (en) | 1991-08-08 |
| US5552275A (en) | 1996-09-03 |
| DE69114323D1 (de) | 1995-12-14 |
| EP0443748A3 (en) | 1991-09-11 |
| AU646655B2 (en) | 1994-03-03 |
| DE69114323T2 (de) | 1996-04-18 |
| EP0443748B1 (de) | 1995-11-08 |
| GB9002625D0 (en) | 1990-04-04 |
| EP0443748A2 (de) | 1991-08-28 |
| CA2035813A1 (en) | 1991-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE130047T1 (de) | Charakterisierung von human-leukocyt-antigen. | |
| AU6180190A (en) | Fast process for detecting and/or identifying a single base on a nucleic acid sequence and its applications | |
| DK0970240T3 (da) | Kunstig fejlparringshydridisering | |
| ATE192503T1 (de) | Manipulation von nukleinsäuresequenzen | |
| EP1034302A4 (de) | De novo oder "universaler" sequenzierungs-array | |
| EP1609875A3 (de) | DNS "Typing" mit Kurzen tandem-repetitiven polimorphismen und Identifikation von Kurzen polimorphen tandem-wiederholungen | |
| IL90357A (en) | Determination of hla-dp allotype and probes therefor | |
| ATE164883T1 (de) | Verfahren zur vorbereitung von doppel strangiger rna und seine anwendungen | |
| Schneider | Basic issues in forensic DNA typing | |
| DE69636080D1 (de) | Eine in Kaskaden verlaufende Vervielfältigungsreaktion von Nukleinsäuren | |
| EP0834575A3 (de) | Verfahren die Zielnukleinsäuren-Patronen auf Oligonukleotid-Matrizzen benutzen | |
| DE69632466D1 (de) | Lösung die chaotropische mittel enthält und verwendung dieser lösung in verfahren zur isolierung von dna, rna und proteinen | |
| DK144886A (da) | Fremgangsmaade til multiplikation af en specifik nukleinsyresekvens | |
| DE69133629D1 (de) | nssystem zur Bestimmung von genetischen Krankheiten | |
| FI904494A0 (fi) | Diagnos- och amplifieringsfoerfaranden foer eliminering av ett primer-maol-opar i primerns 3'-aenda. | |
| ATE196169T1 (de) | Nachweis von treponema pallidum und haemophilus ducreyi | |
| EP0398709A3 (de) | Genetische Diagnose von Torsion-Dystonia | |
| EP0382261A3 (de) | DNS-Sonden gegen VNTR-Orte | |
| ATE204331T1 (de) | Verfahren und system zur molekularbiologischen diagnose | |
| Helminen et al. | Amplification of three hypervariable DNA regions by polymerase chain reaction for paternity determinations: comparison with conventional methods and DNA fingerprinting | |
| Hou et al. | Typing Y chromosome STR haplotypes using redesigned primers | |
| Cucurachi et al. | The evolution of DNA typing in the forensic haemogenetics laboratory of Parma | |
| Bartinez-Jarreta et al. | Mitochondrial DNA HVI and HVII variation in a North-East Spanish population | |
| Alekseev et al. | Molecular-genetic approaches to the study of the HLA system: New horizons in basic research and applied studies | |
| Dobosz et al. | Automated Laser Fluorescent Analysis of Amplified Fragment Length Polymorphisms and Short Tandem Repeats |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |